ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
239.20
2.09
(0.88%)
Closed November 20 4:00PM
238.30
-0.90
( -0.38% )
Pre Market: 8:56AM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
238.30
Bid
-
Ask
-
Volume
3,630
0.00 Day's Range 0.00
148.00 52 Week Range 277.34
Market Cap
Previous Close
239.20
Open
-
Last Trade Time
08:56:29
Financial Volume
-
VWAP
-
Average Volume (3m)
375,128
Shares Outstanding
38,379,199
Dividend Yield
-
PE Ratio
100.93
Earnings Per Share (EPS)
2.37
Revenue
1.06B
Net Profit
90.95M

About Penumbra Inc

Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are primarily sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurova... Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are primarily sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurovascular business, the firm offers products for the neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. Penumbra generates the majority of its revenue in the United States. Show more

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Headquarters
Dover, Delaware, USA
Founded
-
Penumbra Inc is listed in the Surgical,med Instr,apparatus sector of the New York Stock Exchange with ticker PEN. The last closing price for Penumbra was $239.20. Over the last year, Penumbra shares have traded in a share price range of $ 148.00 to $ 277.34.

Penumbra currently has 38,379,199 shares outstanding. The market capitalization of Penumbra is $9.18 billion. Penumbra has a price to earnings ratio (PE ratio) of 100.93.

PEN Latest News

Penumbra, Inc. to Present at the Piper Sandler 36th Annual Healthcare Conference

Penumbra, Inc. to Present at the Piper Sandler 36th Annual Healthcare Conference PR Newswire ALAMEDA, Calif., Nov. 20, 2024 ALAMEDA, Calif., Nov. 20, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE:...

New Late Breaking Data Show Patients Treated with Penumbra's Computer Assisted Vacuum Thrombectomy Technology for Pulmonary Embolism Experience Shorter Hospital Stays and Fewer Complications Compared to Other Treatment Options

New Late Breaking Data Show Patients Treated with Penumbra's Computer Assisted Vacuum Thrombectomy Technology for Pulmonary Embolism Experience Shorter Hospital Stays and Fewer Complications...

Penumbra, Inc. Reports Third Quarter 2024 Financial Results

Penumbra, Inc. Reports Third Quarter 2024 Financial Results PR Newswire ALAMEDA, Calif., Oct. 30, 2024 ALAMEDA, Calif., Oct. 30, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
12.30.974576271186236242.95231.27334708238.46172635CS
433.4116.3063107033204.89243.385203.72425938227.3850996CS
1236.0617.8303006329202.24243.385184.8375128209.27996795CS
2637.6218.7462627068200.68243.385148408035194.94414255CS
522.30.974576271186236277.34148372402211.61746641CS
156-22.26-8.54313785692260.56348.67114.865350280219.23934651CS
26069.7541.382379116168.55348.67114.865349453218.39817679CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PSBDPalmer Square Capital BDC Inc
$ 22.99
(44.32%)
15
ACRACRES Commercial Realty Corporation
$ 23.99
(43.31%)
291
CTVInnovid Corp
$ 2.31
(42.59%)
341.03k
MEGMontrose Environmental Group Inc
$ 25.45
(41.86%)
41
SNDASonida Senior Living
$ 33.00
(38.83%)
23
BTTBlackRock Municipal 2030 Target Term Trust
$ 11.01
(-47.67%)
2
AVNSAvanos Medical Inc
$ 11.01
(-38.39%)
118
SMPStandard Motor Products Inc
$ 20.00
(-36.67%)
106
CBANColony Bankcorp Inc
$ 11.12
(-34.47%)
6
SDHCSmith Douglas Homes Corp
$ 21.00
(-32.78%)
221
SNOWSnowflake Inc
$ 160.74
(24.49%)
1.86M
PLTRPalantir Technologies Inc
$ 61.99
(-0.21%)
1.51M
NIONIO Inc
$ 4.60
(-1.08%)
1.38M
KMIKinder Morgan Inc
$ 28.16
(0.57%)
890.93k
IONQIonQ Inc
$ 28.63
(-0.80%)
879.9k

PEN Discussion

View Posts
@LaughinPaulRyan @LaughinPaulRyan 4 years ago
... ALL NEWS IS GOOD? ... $PEN



CNBC's Scott Wapner reports on why Quintessential Capital Management is shorting Penumbra and why it's questioning the safety of its medical devices.

👍️0
@LaughinPaulRyan @LaughinPaulRyan 4 years ago
QCM legal team filed detailed reports with allegations of misconduct with FDA, SEC and other institutions urging thorough investigation
Deceptive behavior would point to lack of integrity unworthy of management leading $10bn healthcare company and may explain Jet7 crisis leading to multiple deaths, injuries
QCM calls on Adam Elsesser, Arani Bose to resign at once if allegations confirmed
Situation constitutes existential threat to Penumbra’s viability as a public company
👍️0
@LaughinPaulRyan @LaughinPaulRyan 4 years ago
Executive Summary

Large portion of scientific literature produced by Penumbra appears authored by fake character in sophisticated, multi-year deception
Fake character seems fabricated by Penumbra’s management attempting to hide involvement in research with significant undisclosed conflicts of interest
Conflicted research used extensively to market products to healthcare providers, to support FDA applications and to promote stock in IPO
Legal advisers: behavior, if confirmed, may constitute serious fraud threatening revocation of FDA clearances, SEC enforcement and litigation from clients
👍️0
davidsson10 davidsson10 4 years ago
https://www.qcmfunds.com/penumbra-and-its-killer-catheter/?source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link
👍️0
@LaughinPaulRyan @LaughinPaulRyan 4 years ago
... ROFLMFAO ... $PEN

Penumbra Inc
Penumbra, Inc. designs, develops, manufactures, and markets medical devices. The Company offers peripheral vascular and neurovascular devices that help patients suffering from stroke and other neurovascular diseases. Penumbra operates in the United States.
CURRENT PRICE

PEN:US197.48USD-26.54-11.85%AS OF 10:55 AM EST 12/08/2020
👍️0
TREND1 TREND1 9 years ago
IPO INFO

http://www.marketwatch.com/tools/ipo-calendar
👍️0
TREND1 TREND1 9 years ago
IPO NOW HAS SYMBOL
Penumbra PEN
👍️0
TREND1 TREND1 9 years ago
IPO should be out soon.
no symbol yet.
👍️0

Your Recent History

Delayed Upgrade Clock